Summary:
- The article discusses a hearing where lawmakers questioned the leadership of 23andMe, a prominent genetic testing company.
- The hearing focused on concerns about 23andMe's data privacy practices and the potential misuse of genetic information collected from its customers.
- Lawmakers expressed concerns about the company's transparency and the need for stronger regulations to protect consumer privacy in the genetic testing industry.